Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Mike Grey will speak on "What Are the Funding Sources and How to Apply" at the American Chemical Society meeting in San Diego, CA
News | 10. 09. 2010
